25 May 2016
£850,000 project yields two potential new inspection tools for diverse applications in medicine.
One is a lightweight handheld microscope designed to examine external tissue or tissue exposed during surgery. A potential application could be in helping surgeons to compare normal and cancerous cells during an operation. The device can acquire high-quality 3D images of parts of the body even while patients are moving, such as due to normal breathing, enabling it to be applied to almost any exposed area of a patient's body.
The second instrument, a tiny endoscope incorporating specially-designed optical fibers and ultraprecise control of the light coupled into it, has the potential to be inserted into the body to carry out internal cell-scale examination, for example during neurosurgery. Ultimately, this new approach may be able to provide high-resolution images that enable surgeons to see inside individual cells at an adjustable depth beneath the surface of the tissue.
Currently, the diagnosis of many diseases requires taking a tissue specimen from the patient, preparing it in a laboratory, studying it under a microscope and then forwarding the results back to the clinician. The new devices, both of which harness a technique known as multiphoton excited fluorescence microscopy to analyse individual cells in their native tissue, could be used in a consulting room or an operating theatre to help clinicians identify diseased tissue and provide a rapid diagnosis.
The handheld microscope incorporates a tracking mechanism that compensates for the patient's movements, ensuring the generation of steady images. The endoscope is just a fraction of a millimeter in diameter and has no moving parts. Both these devices use novel multicore optical fibers developed by Imperial's collaborators at the University of Bath.
Dr Chris Dunsby of Imperial College London, who has led the overall project, said, “These new devices open up exciting possibilities in the field of in-situ diagnosis and could help improve patient care in the future.” Professor Jonathan Knight, who led the University of Bath team, added, “This has been a very exciting project which has enabled us to develop fibres with performance which we would have previously thought impossible.”
After further development and refinement of the technology, clinical trials will explore the healthcare benefits of the two devices in more detail, with the goal of beginning to introduce them into clinical use within around five to ten years. The 2.5-year research project Development of Multiphoton Microscopes for Real-World Clinical Applications ran from May 2013 to October 2015 and received total EPSRC funding of just over £854,000.
About Multiphoton excitationMultiphoton excitation is where the required excitation is provided by two photons of half the required energy that are absorbed simultaneously. For tissue autofluorescence, this means that the illuminating photons can be near infrared rather than visible light and therefore can penetrate deeper into biological tissue - enabling 3D images to be produced up to ~0.1mm beneath the tissue surface in clinical instruments.
About the Author
Matthew Peach is contributing editor to optics.org.
|Fraunhofer IWS discovering superalloys, new AM processes|
|MIT’s mathematical method tunes metalenses|
|VCSEL maker AMS joins auto lidar development team|
|Ultraviolet-localized photoacoustics improves infrared microscopy of tissues|
|NIST team develops chip-scale optical clock|
|Leti touts 'game-changing' microLED manufacturing process|